913 results on '"Visakorpi, Tapio"'
Search Results
2. Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth
3. Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
4. Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients
5. miR-32 promotes MYC-driven prostate cancer
6. Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment
7. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
8. Androgen deprivation therapy-resistant club cells are linked to myeloid cell-driven immunosuppression in the prostate tumor microenvironment
9. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer
10. Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
11. Long noncoding RNA EPCARTregulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer
12. Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells
13. Retraction Note: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus
14. Integrative proteomics of prostate cancer
15. AR and ERG drive the expression of prostate cancer specific long noncoding RNAs
16. A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer
17. In Vivo Expression of miR-32 Induces Proliferation in Prostate Epithelium
18. Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases
19. Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts
20. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion
21. Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
22. The Molecular Evolution of Castration-resistant Prostate Cancer
23. Differential impact of RB status on E2F1 reprogramming in human cancer
24. Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
25. Abstract 4720: Chromatin conformation alterations in prostate cancer progression and formation of castration resistance
26. Abstract 5644: Spatially resolved transcriptomics points to distinct malignant cell populations within primary and castration resistant prostate cancer
27. Supplementary Table 5 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
28. Supplementary Table 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
29. Data from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
30. Supplementary Table 2 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
31. Supplementary Table 3 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
32. Supplementary Table 4 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
33. Supplementary Tables 1 - 8, Figures 1 - 7 from Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
34. Supplementary Figure 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
35. Data from Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
36. Supplementary Data from Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
37. Data from Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
38. Supplementary Figures S8 & S9 from Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3, the Human UNC-53 Homologue
39. Data from Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
40. Data from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
41. Supplementary Figures 1 - 3 from USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression
42. Supplementary Figure 3 from MicroRNA Expression Profiling in Prostate Cancer
43. Supplementary Tables 1-9 from Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
44. Supplementary Figure 2 from MicroRNA Expression Profiling in Prostate Cancer
45. Supplementary Table 1 from USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression
46. Supplementary Table 1 from MicroRNA Expression Profiling in Prostate Cancer
47. Supplementary Table S4 from Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
48. Supplementary Figure 5 from Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
49. Supplementary Methods, Figure Legend from Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
50. Supplementary Figure 1 from Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.